Tilray (NASDAQ:TLRY) Reports Sales Below Analyst Estimates In Q4 Earnings
Cannabis company Tilray Brands (NASDAQ:TLRY) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 8.9% year on year to $211 million. On the other hand, the company’s full-year revenue guidance of $975 million at the midpoint came in 8.
Shares of cannabis company Tilray Brands (NASDAQ:TLRY) fell 13.5% in the morning session after the company reported ...
Stock futures dipped on Friday as investors evaluated a much hotter-than-expected December jobs report and awaited the ...
Tilray Brands Inc.’s stock fell Friday after the beer and cannabis company said it expects a $20 million impact on its ...
Tilray Brands reported 9% YoY revenue growth in Q2 2025 to $210.95 million. Fiscal 2025 guidance remains strong at $950 ...
Reports Q2 net revenue $211M, consensus $216.33M. Irwin Simon, Chairman and CEO of Tilray (TLRY) Brands, stated, “In our fiscal second quarter, ...
The upcoming week will see a pick-up in earnings releases after little activity over the past couple holiday-shortened weeks.
New York hits $1B cannabis sales, Ukraine registers first medical product. Updates on DoorDash, Tilray, Agrify and more.
Tilray Brands Inc. closed $1.60 short of its 52-week high ($2.97), which the company reached on April 4th.
Tilray Brands (TLRY) stock falls 8% in premarket after Q2 revenue misses estimates. However, company reaffirms FY25 guidance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback